AgingResearch.NewsJoin free

K14q-MOTS-c

K14q-MOTS-c has been studied in 1 paper since 2021: 1 observational study in people. The newest paper, Jan 19, 2021: “A pro-diabetogenic mtDNA polymorphism in the mitochondrial-derived peptide, MOTS-c”.

Intervention

1 paper studies it1 findingUpdated

More peptides

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

  • 1 lab in 1 country
  • Funders: Japan Society for the Promotion of Science and 6 more
  • Humans1

What did studies of K14q-MOTS-c find?

1

Studies of K14q-MOTS-c measured 1 outcome; the most studied are glucose tolerance (1 study).

Glucose tolerance

no changein mice1

1 study

  1. K14q-MOTS-c has no effect on glucose tolerance in mice.

    “High-fat fed, male mice injected with MOTS-c showed reduced weight and improved glucose tolerance, but not K14Q-MOTS-c treated mice.”

    Animalshigh-fat fedmales

    A pro-diabetogenic mtDNA polymorphism in the mitochondrial-derived peptide, MOTS-c

    Aging

Latest

Related